William Watts is MarketWatch markets editor. In addition to managing markets coverage, he writes about stocks, bonds, currencies and commodities, including oil. He also writes about global macro issu… [+155 chars]Read More
Related Posts
Viking Therapeutics loses a third of its value after oral weightloss drug trial MarketWatch
Viking Therapeutics loses a third of its value after oral weight-loss drug trial - MarketWatch
Stockmarket winners suffered their worst day in six years Heres what made the move really…
Stock-market winners suffered their worst day in six years. Here’s what made the move really unusual, according to Goldman. - MarketWatch
SP 500 may be up in June but Iran attacks and tariff fears are good…
‘We’re entering the greater-fool phase,’ cautions Wells Fargo’s Sameer Samana
